Et al Phillip Frost MD - Director, 10%+ Owner at Cocrystal Pharma, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Et al Phillip Frost MD in Cocrystal Pharma, Inc.

Buys

Open market
Shares
+314,000
Avg price
$0.9561
Total value
+$300,212

Sells

Open market
Shares
Avg price
Total value

Net

Past year
Shares
+314,000
Share %
100%
Total value
+$300,212

Reported holdings for Et al Phillip Frost MD in Cocrystal Pharma, Inc.

Form 4 holding Director, 10%+ Owner

Cocrystal Pharma, Inc.

Security class
Warrants
Shares / value
719,426
Estimated value
$1,000,002
Report date
28 Oct 2025
Price
$1.39
Ownership
By Frost Gamma Investments Trust
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Cocrystal Pharma, Inc.

Security class
Stock Options (Right to Buy)
Shares / value
24,615
Estimated value
Report date
09 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Et al Phillip Frost MD in Cocrystal Pharma, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .